Literature DB >> 2891991

Induction of therapeutic abortion in early pregnancy with mifepristone in combination with prostaglandin pessary.

M W Rodger1, D T Baird.   

Abstract

Therapeutic abortion was induced in 100 women in early pregnancy (less than 56 days' amenorrhoea) with a combination of the antigestagen mifepristone (RU 486) and a synthetic prostaglandin analogue, gemeprost. Mifepristone in oral doses of 400-600 mg was followed 48 h later by a gemeprost vaginal pessary (0.5-1.0 mg). Bleeding was induced in all women 22-70 h after the mifepristone dose and although bleeding continued for 4-43 days (median 12) the total measured blood-loss was only a median of 72.5 ml (range 15-398). Complete abortion occurred in 95 women. Surgical evacuation of the uterus for minimum debris was required in the remaining 5. Only 10 women had diarrhoea or pain that required opioid analgesia. The combination of mifepristone and gemeprost provides a safe and effective alternative to surgical evacuation of the uterus for therapeutic abortion in early pregnancy.

Entities:  

Keywords:  Abortion, Drug Induced; Abortion, Induced; Abortion, Therapeutic--complications; Biology; Carboxylic Acids; Comparative Studies; Developed Countries; Diarrhea; Diseases; Drugs--administraction and dosage; Endocrine System; Europe; Family Planning; Fertility Control, Postconception; Gastrointestinal Effects; Ingredients And Chemicals; Nausea; Northern Europe; Organic Chemicals; Pain; Physiology; Prostaglandins; Research Methodology; Scotland; Signs And Symptoms; Studies; Treatment; United Kingdom; Vomiting

Mesh:

Substances:

Year:  1987        PMID: 2891991     DOI: 10.1016/s0140-6736(87)91126-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  9 in total

Review 1.  Medical termination of pregnancy.

Authors:  J Guillebaud
Journal:  BMJ       Date:  1990 Aug 18-25

Review 2.  International developments in abortion laws: 1977-88.

Authors:  R J Cook; B M Dickens
Journal:  Am J Public Health       Date:  1988-10       Impact factor: 9.308

3.  Termination of pregnancy with reduced doses of mifepristone. World Health Organisation Task Force on Post-ovulatory Methods of Fertility Regulation.

Authors: 
Journal:  BMJ       Date:  1993-08-28

Review 4.  Mifepristone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential.

Authors:  R N Brogden; K L Goa; D Faulds
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

Review 5.  Antiprogestin pharmacodynamics, pharmacokinetics, and metabolism: implications for their long-term use.

Authors:  G R Jang; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1997-12

Review 6.  Medical approaches to termination of early pregnancy.

Authors:  P F Van Look; M Bygdeman
Journal:  Bull World Health Organ       Date:  1989       Impact factor: 9.408

Review 7.  Emerging options for emergency contraception.

Authors:  Atsuko Koyama; Laura Hagopian; Judith Linden
Journal:  Clin Med Insights Reprod Health       Date:  2013-02-18

8.  Progesterone after previous preterm birth for prevention of neonatal respiratory distress syndrome (PROGRESS): a randomised controlled trial.

Authors:  Jodie M Dodd; Caroline A Crowther; Andrew J McPhee; Vicki Flenady; Jeffrey S Robinson
Journal:  BMC Pregnancy Childbirth       Date:  2009-02-24       Impact factor: 3.007

9.  Glucocorticoid-mediated control of the activation and clonal deletion of peripheral T cells in vivo.

Authors:  J A Gonzalo; A González-García; C Martínez; G Kroemer
Journal:  J Exp Med       Date:  1993-05-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.